大众筛查市场规模,份额和趋势分析报告:按地区(国家,州),按产品(硬件设备),按业务(医院),按性别,按类型,按年龄,按地区,分部预测2023-2030

团体体检市场增长及趋势

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球大规模筛查市场预计将达到 382 亿美元。从 2023 年到 2030 年，该市场预计将以 5.36% 的复合年增长率增长。市场增长归因于疾病流行率的增加、老年人口的增加、对大规模筛查测试的投资增加等。此外，这些测试中不断增加的技术进步和发展预计将显着推动市场。

预计心血管疾病患病率上升将推动该领域的增长。据世界卫生组织统计，心血管疾病每年导致 1770 万人死亡，占全球所有死亡人数的 31.0%。高血压及其不利的病态影响也使人们更容易患上其他心脏病，例如心力衰竭和中风。世界范围内有多种材料原纤化筛查项目，旨在降低死亡率。早期识别高血压和其他心血管疾病对于预测和预防与这些疾病相关的主要死亡率和发病率具有重要意义。

脊髓性肌萎缩症 (SMA) 等罕见遗传病的患病率上升以及人口筛查支出的增加是市场主导地位的主要驱动因素。根据国家罕见病组织 (NORD) 的数据，SMA 影响了全世界大约 10,000 人中的 1 人。据 SMA Canada 称，截至 2022 年 7 月，据信加拿大约有 700 人患有这种疾病。例如，CDC 已根据全州通用新生儿计划向每个州发布了推荐的统一筛查小组 (RUSP)，以早期发现患有 SMA 的儿童。因此，政府正在采取此类举措进行人口筛查，从而支持大规模筛查市场的增长。

市场参与者正在采用产品发布策略来加强他们的产品组合，并为患者提供多样化、技术先进和创新的大规模筛查产品。一些市场参与者正在进行併购以加强其市场地位。这种战略使公司能够增加他们的能力，扩大他们的产品组合併提高他们的能力。例如，2022 年 8 月，Thermo Fisher Scientific 推出了 HIV-1 基因分型试剂盒，用于识别抗逆转录病毒疗法 (ART) 抵抗的基因突变。该试剂盒仅用于研究目的。

大众筛查市场报告亮点

由于 CTC 提供的癌症检测的有效性和准确性，2022 年的市场细分将由国家细分市场主导

由于私人放映计划的增加，预计在预测期内，高端市场将以最快的速度增长。

由于女性进行的测试数量增加，女性细分市场将成为 2022 年创收最高的细分市场

由于各国政府采取预防措施阻止疾病的发展，北美将在 2022 年主导大规模筛查市场。

目录

第一章 调查方法和范围

• 市场细分
• 调查方法
• 信息采购
  • 购买的数据库
  • 次要信息
  • 初步调查
  • 初步调查详情
• 信息或数据分析
  • 数据分析模型
• 市场製定和验证
• 型号详情
  • 商品流向分析
    • 方法一:商品流动方法
    • 方法 2:使用自下而上的方法进行国别市场估算
• 全球市场:复合年增长率计算
• 调查假设
• 二级信息列表
• 主要信息列表
• 目的
• 缩略语表

第二章执行摘要

• 市场快照
• 段快照
• 竞争格局的快照

3. 大规模筛查市场变量、趋势和范围

• 大众筛查市场体系展望
  • 母公司市场展望
    • 细胞健康筛查市场展望
    • 体外诊断市场展望
• 绘製渗透率和增长前景
• 市场驱动力分析
  • 疾病流行率增加
  • 增加对大规模筛查的投资
  • 老年人口不断增长
• 市场约束因素分析
  • 与筛查相关的高成本
  • 心理因素、知识、态度、信念
• 按因素（政治和法律、经济、技术）的 SWOT 分析
• 波特五力分析
• 监管框架

第 4 章大众筛查市场细分分析，按地区，区域年份从 2018 年开始（百万美元）

• 定义和范围
• 大众筛查市场:区域差异分析
  • 国家
  • 状态

5 大众筛查市场-细分分析，副产品，2018-2030（百万美元）

• 大众筛查市场:产品差异分析
  • 硬件设备（器件、套件、芯片）
  • 测试/实验室（服务）
  • 分析/解释（个性化和解释）

6. 大众筛查市场-细分分析，按业务划分，2018-2030 年（百万美元）

• 定义和范围
• 体检市场:业务波动分析
  • 医院
  • 调查
  • 诊断实验室

7. 大众筛查市场-细分分析，性别，2018-2030（百万美元）

• 定义和范围
• 大众筛查市场:性别差异分析
  • 男人
  • 女士

8 大众筛查市场 - 细分分析，按类型，2018-2030（百万美元）

• 定义和范围
• 大规模筛查市场:类型差异分析
  • 大量的
  • 优质的

9 大众筛查市场 - 细分分析，按年龄划分，2018-2030 年（百万美元）

• 定义和范围
• 大众筛查市场:年龄变化分析
  • 15岁以下
    • 根据 15 项市场估计和预测，2018-2030 年（百万美元）
  • 15-65岁
  • 65+

第10章区域业务分析

• 定义和范围
• 2021 年和 2030 年区域市场份额分析
• 区域市场仪表板
• 区域市场快照
• SWOT 分析，按因素（政治和法律、经济和技术）
  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 多边环境协定
• 2021-2030 年市场规模、预测和趋势分析
• 北美
  • 美国
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 加拿大
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
• 欧洲
  • 英国
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 德国
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 西班牙
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 法国
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 意大利
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 丹麦
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 瑞典
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 挪威
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
• 亚太地区
  • 日本
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 中国
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 印度
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 韩国
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 泰国
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 澳大利亚
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
• 拉丁美洲
  • 巴西
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 墨西哥
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 阿根廷
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
• 多边环境协定
  • 南非
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 沙特阿拉伯
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 阿拉伯联合酋长国
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景
  • 科威特
    • 主要国家动态
    • 监管框架
    • 竞争情景
    • 最近的发展
    • 投资场景

第 11 章 竞争分析

• 公司/竞争对手分类（主要创新者、市场领导者、初创企业）
• 战略框架
• 市场参与的分类
• 主要市场进入者的最新发展和影响分析
• 公司定位分析
• 代理商名单
  • 主要客户
  • 上市公司
  • 民营企业
• 案例分析
  • 筛查与未筛查 Cvd 患者的成本分析
  • 案例研究:大众健康检查
  • 案例研究:使用 Agilent Quickprobe GC/M 系统检查原始样本
  • 案例研究:评估 Roche Cobas 4800 HPV 测试的性能以评估用于筛查的 HPV 测试
  • 案例研究:测量糖尿病患者的葡萄糖和血红蛋白

第十二章公司简介

• 公司简介
  • AGILENT TECHNOLOGIES, INC.
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • THERMO FISHER SCIENTIFIC, INC.
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • QIAGEN
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • F. HOFFMANN-LA ROCHE LTD
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • QUEST DIAGNOSTICS
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • ILLUMINA, INC
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • ARUP LABORATORIES
    • 公司简介
    • 产品基准
    • 战略举措
  • NOVOGENE CO., LTD.
    • 公司简介
    • 产品基准
    • 战略举措
  • LGC LIMITED
    • 公司简介
    • 产品基准
    • 战略举措
  • GENE BY GENE, LTD.
    • 公司简介
    • 产品基准

Population Screening Market Growth & Trends:

The global population screening market size is expected to reach USD 38.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.36% from 2023 to 2030. The growth of the market is attributed to the increasing prevalence of diseases, the growing geriatric population, and increasing investment in population screening tests. Moreover, the market is expected to be driven significantly by increasing technological advancements and developments in these tests.

An increase in the prevalence of cardiovascular diseases is expected to boost segment growth. According to the WHO, 17.7 million people die annually due to cardiovascular diseases, which is 31.0% of the total deaths occurring worldwide. Cardiovascular diseases are the leading cause of mortality and morbidity in the U.S. They are among the main causes of death globally, and hypertension & its pathological adverse effects pose a significant risk for other cardiac diseases, such as heart failure & stroke. There are multiple screening programs available for material fibrillation globally that aim to reduce the mortality rate. Identifying early-stage hypertension and other CVDs is of high significance in predicting & preventing major mortality & morbidity related to these diseases.

The growing prevalence of rare genetic diseases such as Spinal Muscular Atrophy (SMA) disorders and increased spending on population screening are among the major factors for the dominance of the market. According to the National Organization for Rare Disorders (NORD), SMA affects almost one in 10,000 people globally. In addition, according to SMA Canada, approximately 700 people were living with this condition in Canada as of July 2022. For instance, the CDC released the Recommended Uniform Screening Panel (RUSP) to states under its statewide universal newborn programs for the early identification of children with SMA. Thus, such initiatives are undertaken by governments to screen the population, thereby supporting the growth of the population screening market.

Players in the market adopt the strategy of product launches to strengthen their product portfolio and offer diverse, technologically advanced, & innovative population screening products to patients. Several market players engage in mergers & acquisitions to strengthen their market position. This strategy enables companies to boost their capabilities, expand product portfolios, and improve competencies. For instance, in August 2022, Thermo Fisher Scientific, Inc., launched an HIV-1 genotyping kit to identify the genetic mutations that resist Antiretroviral Therapeutics (ART). This kit was intended only for research purposes.

Population Screening Market Report Highlights:

• The nation segment held a dominant share of the market in 2022 owing to the effectiveness and precision offered by CTCs in the detection of cancer

• The premium segment is projected to grow at the fastest rate over the forecast period owing to the increasing dominance of private screening programs

• The female segment is the highest revenue-generating segment in 2022 owing to the increasing number of tests being performed by females

• North America dominated the population screening market in 2022, which is attributed to preventive measures undertaken by governments to stop the progression of diseases

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation
  • 1.1.1 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 Secondary Sources
  • 1.3.3 Primary Research
  • 1.3.4 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
• 1.7 Global Market: CAGR Calculation
• 1.8 Research Assumptions
• 1.9 List of Secondary Sources
• 1.10 List of Primary Sources
• 1.11 Objectives
  • 1.11.1 Objective 1
  • 1.11.2 Objective 2
• 1.12 List of Abbreviations

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Snapshot
• 2.3 Competitive Landscape Snapshot

Chapter 3 Popular Screening Market Variables, Trends & Scope

• 3.1 Population Screening Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
    • 3.1.1.1 Cellular Health Screening Market Outlook
    • 3.1.1.2 In Vitro Diagnostics Market Outlook
• 3.2 Penetration and Growth Prospect Mapping
• 3.3 Market Driver Analysis
  • 3.3.1 Increasing Prevalence Of Diseases
  • 3.3.2 Growing Investments In Population Screening
  • 3.3.3 Growing Geriatric Population
• 3.4 Market Restraint Analysis
  • 3.4.1 High Cost Associated With Screening
  • 3.4.2 Psychological Factors, Knowledge, Attitudes, And Beliefs
• 3.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
• 3.6 Porter's Five Forces Analysis
• 3.7 Regulatory Framework

Chapter 4 Population Screening Market - Segment Analysis, by Geography, 2018 - 2030 (USD Million)

• 4.1 Definition and Scope
• 4.2 Population Screening Market: Geography Movement Analysis
  • 4.2.1 Nation
    • 4.2.1.1 Nation Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.2.2 State
    • 4.2.2.1 State market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Population Screening Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

• 5.1 Population Screening Market: Product Movement Analysis
  • 5.1.1 Hardware Equipment (Instrument, Kits, Chips)
    • 5.1.1.1 Hardware Equipment (Instrument, Kits, Chips) Market Estimates And Forecast, 2018 - 2030 (Usd Million)
  • 5.1.2 Testing/Lab (Services)
    • 5.1.2.1 Testing/Lab (Services) Market Estimates And Forecast, 2018 - 2030 (Usd Million)
  • 5.1.3 Analytics/Interpretation (Personalization And Interpretation)
    • 5.1.3.1 Analytics/Interpretation (Personalisation and interpretation) market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Population Screening Market - Segment Analysis, by Business, 2018 - 2030 (USD Million)

• 6.1 Definition and Scope
• 6.2 Population Screening Market: Business Movement Analysis
  • 6.2.1 Hospitals
    • 6.2.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (Usd Million)
  • 6.2.2 Research Institutes
    • 6.2.2.1 Research Institutes Market Estimates And Forecast, 2018 - 2030 (Usd Million)
  • 6.2.3 Diagnostic Labs
    • 6.2.3.1 Diagnostic labs market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Population Screening Market - Segment Analysis, by Gender, 2018 - 2030 (USD Million)

• 7.1 Definition and Scope
• 7.2 Population Screening Market: Gender Movement Analysis
  • 7.2.1 Male
    • 7.2.1.1 Male Market Estimates And Forecast, 2018 - 2030 (Usd Million)
  • 7.2.2 Female
    • 7.2.2.1 Female market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Population Screening Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

• 8.1 Definition and Scope
• 8.2 Population Screening Market: Type Movement Analysis
  • 8.2.1 Mass
    • 8.2.1.1 Mass Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.2.2 Premium
    • 8.2.2.1 Premium market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Population Screening Market - Segment Analysis, by Age, 2018 - 2030 (USD Million)

• 9.1 Definition and Scope
• 9.2 Population Screening Market: Age Movement Analysis
  • 9.2.1 Age <15
    • 9.2.1.1 Age <15 Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 9.2.2 15-65
    • 9.2.2.1 15-65 Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 9.2.3 Ages 65+
    • 9.2.3.1 Ages 65+ market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 10 Regional Business Analysis

• 10.1 Definition & Scope
• 10.2 Regional Market Share Analysis, 2021 & 2030
• 10.3 Regional Market Dashboard
• 10.4 Regional Market Snapshot
• 10.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
  • 10.5.1 North America
  • 10.5.2 Europe
  • 10.5.3 Asia Pacific
  • 10.5.4 Latin America
  • 10.5.5 MEA
• 10.6 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
• 10.7 North America
  • 10.7.1 North America Market Estimates And Forecast, 2018 - 2030 (USD MILLION)
  • 10.7.2 U.S.
    • 10.7.2.1 U.S. Population Screening Market, 2018 - 2030 (USD Million)
    • 10.7.2.2 Key country Dynamics
    • 10.7.2.3 Regulatory Framework
    • 10.7.2.4 Competitive Scenario
    • 10.7.2.5 Recent Developments
    • 10.7.2.6 Investments Scenario
  • 10.7.3 Canada
    • 10.7.3.1 Canada Population Screening Market, 2018 - 2030 (USD Million)
    • 10.7.3.2 Key country Dynamics
    • 10.7.3.3 Regulatory Framework
    • 10.7.3.4 Competitive Scenario
    • 10.7.3.5 Recent Developments
    • 10.7.3.6 Investments Scenario
• 10.8 Europe
  • 10.8.1 Europe Population Screening Market, 2018 - 2030 (USD Million)
  • 10.8.2 UK
    • 10.8.2.1 UK Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.2.2 Key country Dynamics
    • 10.8.2.3 Regulatory Framework
    • 10.8.2.4 Competitive Scenario
    • 10.8.2.5 Recent Developments
    • 10.8.2.6 Investments Scenario
  • 10.8.3 Germany
    • 10.8.3.1 Germany Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.3.2 Key country Dynamics
    • 10.8.3.3 Regulatory Framework
    • 10.8.3.4 Competitive Scenario
    • 10.8.3.5 Recent Developments
    • 10.8.3.6 Investments Scenario
  • 10.8.4 Spain
    • 10.8.4.1 Spain Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.4.2 Key country Dynamics
    • 10.8.4.3 Regulatory Framework
    • 10.8.4.4 Competitive Scenario
    • 10.8.4.5 Recent Developments
    • 10.8.4.6 Investments Scenario
  • 10.8.5 France
    • 10.8.5.1 France Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.5.2 Key country Dynamics
    • 10.8.5.3 Regulatory Framework
    • 10.8.5.4 Competitive Scenario
    • 10.8.5.5 Recent Developments
    • 10.8.5.6 Investments Scenario
  • 10.8.6 Italy
    • 10.8.6.1 Italy Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.6.2 Key country Dynamics
    • 10.8.6.3 Regulatory Framework
    • 10.8.6.4 Competitive Scenario
    • 10.8.6.5 Recent Developments
    • 10.8.6.6 Investments Scenario
  • 10.8.7 Denmark
    • 10.8.7.1 Denmark Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.7.2 Key country Dynamics
    • 10.8.7.3 Regulatory Framework
    • 10.8.7.4 Competitive Scenario
    • 10.8.7.5 Recent Developments
    • 10.8.7.6 Investments Scenario
  • 10.8.8 Sweden
    • 10.8.8.1 Sweden Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.8.2 Key country Dynamics
    • 10.8.8.3 Regulatory Framework
    • 10.8.8.4 Competitive Scenario
    • 10.8.8.5 Recent Developments
    • 10.8.8.6 Investments Scenario
  • 10.8.9 Norway
    • 10.8.9.1 Norway Population Screening Market, 2018 - 2030 (USD Million)
    • 10.8.9.2 Key country Dynamics
    • 10.8.9.3 Regulatory Framework
    • 10.8.9.4 Competitive Scenario
    • 10.8.9.5 Recent Developments
    • 10.8.9.6 Investments Scenario
• 10.9 Asia Pacific
  • 10.9.1 Asia-Pacific Population Screening Market, 2018 - 2030 (USD Million)
  • 10.9.2 Japan
    • 10.9.2.1 Japan Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.9.2.2 Key Country Dynamics
    • 10.9.2.3 Regulatory Framework
    • 10.9.2.4 Competitive Scenario
    • 10.9.2.5 Recent Developments
    • 10.9.2.6 Investments Scenario
  • 10.9.3 China
    • 10.9.3.1 China Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.9.3.2 Key Country Dynamics
    • 10.9.3.3 Regulatory Framework
    • 10.9.3.4 Competitive Scenario
    • 10.9.3.5 Recent Developments
    • 10.9.3.6 Investments Scenario
  • 10.9.4 India
    • 10.9.4.1 India Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.9.4.2 Key Country Dynamics
    • 10.9.4.3 Regulatory Framework
    • 10.9.4.4 Competitive Scenario
    • 10.9.4.5 Recent Developments
    • 10.9.4.6 Investments Scenario
  • 10.9.5 South Korea
    • 10.9.5.1 South Korea Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.9.5.2 Key Country Dynamics
    • 10.9.5.3 Regulatory Framework
    • 10.9.5.4 Competitive Scenario
    • 10.9.5.5 Recent Developments
    • 10.9.5.6 Investments Scenario
  • 10.9.6 Thailand
    • 10.9.6.1 Thailand Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.9.6.2 Key Country Dynamics
    • 10.9.6.3 Regulatory Framework
    • 10.9.6.4 Competitive Scenario
    • 10.9.6.5 Recent Developments
    • 10.9.6.6 Investments Scenario
  • 10.9.7 Australia
    • 10.9.7.1 Australia Population Screening Market, 2018 - 2030 (USD Million)
    • 10.9.7.2 Key country Dynamics
    • 10.9.7.3 Regulatory Framework
    • 10.9.7.4 Competitive Scenario
    • 10.9.7.5 Recent Developments
    • 10.9.7.6 Investments Scenario
• 10.10 Latin America
  • 10.10.1 Latin America Population Screening Market, 2018 - 2030 (USD Million)
  • 10.10.2 Brazil
    • 10.10.2.1 Brazil Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.10.2.2 Key Country Dynamics
    • 10.10.2.3 Regulatory Framework
    • 10.10.2.4 Competitive Scenario
    • 10.10.2.5 Recent Developments
    • 10.10.2.6 Investments Scenario
  • 10.10.3 Mexico
    • 10.10.3.1 Mexico Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.10.3.2 Key Country Dynamics
    • 10.10.3.3 Regulatory Framework
    • 10.10.3.4 Competitive Scenario
    • 10.10.3.5 Recent Developments
    • 10.10.3.6 Investments Scenario
  • 10.10.4 Argentina
    • 10.10.4.1 Argentina Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.10.4.2 Key Country Dynamics
    • 10.10.4.3 Regulatory Framework
    • 10.10.4.4 Competitive Scenario
    • 10.10.4.5 Recent Developments
    • 10.10.4.6 Investments Scenario
• 10.11 MEA
  • 10.11.1 Mea Population Screening Market, 2018 - 2030 (Usd Million)
  • 10.11.2 South Africa
    • 10.11.2.1 South Africa Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.11.2.2 Key Country Dynamics
    • 10.11.2.3 Regulatory Framework
    • 10.11.2.4 Competitive Scenario
    • 10.11.2.5 Recent Developments
    • 10.11.2.6 Investments Scenario
  • 10.11.3 Saudi Arabia
    • 10.11.3.1 Saudi Arabia Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.11.3.2 Key Country Dynamics
    • 10.11.3.3 Regulatory Framework
    • 10.11.3.4 Competitive Scenario
    • 10.11.3.5 Recent Developments
    • 10.11.3.6 Investments Scenario
  • 10.11.4 UAE
    • 10.11.4.1 Uae Population Screening Market, 2018 - 2030 (Usd Million)
    • 10.11.4.2 Key Country Dynamics
    • 10.11.4.3 Regulatory Framework
    • 10.11.4.4 Competitive Scenario
    • 10.11.4.5 Recent Developments
    • 10.11.4.6 Investments Scenario
  • 10.11.5 Kuwait
    • 10.11.5.1 Kuwait Population Screening Market, 2018 - 2030 (USD Million)
    • 10.11.5.2 Key country Dynamics
    • 10.11.5.3 Regulatory Framework
    • 10.11.5.4 Competitive Scenario
    • 10.11.5.5 Recent Developments
    • 10.11.5.6 Investments Scenario

Chapter 11 Competitive Analysis

• 11.1 Company/Competition Categorization (Key Innovators, Market leaders, Emerging Players)
• 11.2 Strategy Framework
• 11.3 Market Participation Categorization
• 11.4 Recent Developments & Impact Analysis, by Key Market Participants
• 11.5 Company Position Analysis
• 11.6 List of Distributors
  • 11.6.1 Key Customers
  • 11.6.2 Public Companies
  • 11.6.3 Private Companies
• 11.7 Case Studies
  • 11.7.1 Cost Analysis Of Cvd Patients With Screening Vs No Screening
  • 11.7.2 Case Study: Population Health Screening
  • 11.7.3 Case Study: Screening Of Raw Cases Samples Using The Agilent Quickprobe Gc/Ms System
  • 11.7.4 Case Study: Evaluate The Performance Of Roche Cobas 4800 Hpv Test For Evaluating Hpv Tests For Screening
  • 11.7.5 Case Study: Measurement Of Glucose And Hemoglobin In Diabetes

Chapter 12 COMPANY PROFILES

• 12.1 Company Profiles
  • 12.1.1 AGILENT TECHNOLOGIES, INC.
    • 12.1.1.1 Company Overview
    • 12.1.1.2 Financial Performance
    • 12.1.1.3 Product Benchmarking
    • 12.1.1.4 Strategic Initiatives
  • 12.1.2 THERMO FISHER SCIENTIFIC, INC.
    • 12.1.2.1 Company Overview
    • 12.1.2.2 Financial performance
    • 12.1.2.3 Product Benchmarking
    • 12.1.2.4 Strategic Initiatives
  • 12.1.3 QIAGEN
    • 12.1.3.1 Company Overview
    • 12.1.3.2 Financial performance
    • 12.1.3.3 Product Benchmarking
    • 12.1.3.4 Strategic Initiatives
  • 12.1.4 F. HOFFMANN-LA ROCHE LTD
    • 12.1.4.1 Company Overview
    • 12.1.4.2 Financial performance
    • 12.1.4.3 Product Benchmarking
    • 12.1.4.4 Strategic Initiatives
  • 12.1.5 QUEST DIAGNOSTICS
    • 12.1.5.1 Company Overview
    • 12.1.5.2 Financial performance
    • 12.1.5.3 Product Benchmarking
    • 12.1.5.4 Strategic Initiatives
  • 12.1.6 ILLUMINA, INC
    • 12.1.6.1 Company Overview
    • 12.1.6.2 Financial performance
    • 12.1.6.3 Product Benchmarking
    • 12.1.6.4 Strategic Initiatives
  • 12.1.7 ARUP LABORATORIES
    • 12.1.7.1 Company Overview
    • 12.1.7.2 Product Benchmarking
    • 12.1.7.3 Strategic Initiatives
  • 12.1.8 NOVOGENE CO., LTD.
    • 12.1.8.1 Company Overview
    • 12.1.8.2 Product Benchmarking
    • 12.1.8.3 Strategic Initiatives
  • 12.1.9 LGC LIMITED
    • 12.1.9.1 Company Overview
    • 12.1.9.2 Product Benchmarking
    • 12.1.9.3 Strategic Initiatives
  • 12.1.10 GENE BY GENE, LTD.
    • 12.1.10.1 Company Overview
    • 12.1.10.2 Product Benchmarking

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Regulatory Framework
• Table 4 Global Population Screening Market, By Region, 2018 - 2030 (USD Million)
• Table 5 Global Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 6 Global Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 7 Global Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 8 Global Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 9 Global Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 10 Global Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 11 North America Population Screening Market, By Country, 2018 - 2030, (USD Million)
• Table 12 North America Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 13 North America Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 14 North America Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 15 North America Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 16 North America Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 17 North America Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 18 U.S. Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 19 U.S. Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 20 U.S. Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 21 U.S. Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 22 U.S. Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 23 U.S. Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 24 Canada Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 25 Canada Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 26 Canada Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 27 Canada Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 28 Canada Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 29 Canada Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 30 Europe Population Screening Market, By Country, 2018 - 2030, (USD Million)
• Table 31 Europe Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 32 Europe Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 33 Europe Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 34 Europe Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 35 Europe Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 36 Europe Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 37 UK Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 38 UK Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 39 UK Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 40 UK Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 41 UK Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 42 UK Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 43 Germany Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 44 Germany Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 45 Germany Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 46 Germany Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 47 Germany Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 48 Germany Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 49 France Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 50 France Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 51 France Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 52 France Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 53 France Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 54 France Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 55 Spain Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 56 Spain Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 57 Spain Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 58 Spain Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 59 Spain Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 60 Spain Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 61 Italy Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 62 Italy Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 63 Italy Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 64 Italy Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 65 Italy Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 66 Italy Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 67 Denmark Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 68 Denmark Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 69 Denmark Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 70 Denmark Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 71 Denmark Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 72 Denmark Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 73 Sweden Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 74 Sweden Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 75 Sweden Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 76 Sweden Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 77 Sweden Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 78 Sweden Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 79 Norway Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 80 Norway Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 81 Norway Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 82 Norway Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 83 Norway Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 84 Norway Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 85 Asia Pacific Population Screening Market, By Country, 2018 - 2030, (USD Million)
• Table 86 Asia Pacific Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 87 Asia Pacific Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 88 Asia Pacific Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 89 Asia Pacific Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 90 Asia Pacific Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 91 Asia Pacific Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 92 Japan Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 93 Japan Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 94 Japan Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 95 Japan Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 96 Japan Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 97 Japan Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 98 China Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 99 China Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 100 China Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 101 China Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 102 China Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 103 China Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 104 Australia Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 105 Australia Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 106 Australia Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 107 Australia Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 108 Australia Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 109 Australia Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 110 Thailand Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 111 Thailand Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 112 Thailand Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 113 Thailand Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 114 Thailand Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 115 Thailand Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 116 India Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 117 India Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 118 India Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 119 India Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 120 India Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 121 India Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 122 South Korea Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 123 South Korea Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 124 South Korea Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 125 South Korea Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 126 South Korea Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 127 South Korea Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 128 Latin America Population Screening Market, By Country, 2018 - 2030, (USD Million)
• Table 129 Latin America Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 130 Latin America Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 131 Latin America Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 132 Latin America Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 133 Latin America Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 134 Latin America Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 135 Mexico Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 136 Mexico Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 137 Mexico Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 138 Mexico Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 139 Mexico Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 140 Mexico Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 141 Brazil Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 142 Brazil Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 143 Brazil Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 144 Brazil Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 145 Brazil Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 146 Brazil Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 147 Argentina Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 148 Argentina Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 149 Argentina Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 150 Argentina Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 151 Argentina Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 152 Argentina Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 153 MEA Population Screening Market, By Country, 2018 - 2030, (USD Million)
• Table 154 MEA Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 155 MEA Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 156 MEA Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 157 MEA Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 158 MEA Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 159 MEA Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 160 South Africa Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 161 South Africa Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 162 South Africa Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 163 South Africa Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 164 South Africa Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 165 South Africa Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 166 South Africa Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 167 Saudi Arabia Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 168 Saudi Arabia Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 169 Saudi Arabia Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 170 Saudi Arabia Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 171 Saudi Arabia Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 172 Saudi Arabia Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 173 Saudi Arabia Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 174 UAE Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 175 UAE Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 176 UAE Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 177 UAE Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 178 UAE Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 179 UAE Population Screening Market, By Age, 2018 - 2030 (USD Million)
• Table 180 Kuwait Population Screening Market, By Geography, 2018 - 2030 (USD Million)
• Table 181 Kuwait Population Screening Market, By Product, 2018 - 2030 (USD Million)
• Table 182 Kuwait Population Screening Market, By Business, 2018 - 2030 (USD Million)
• Table 183 Kuwait Population Screening Market, By Gender, 2018 - 2030 (USD Million)
• Table 184 Kuwait Population Screening Market, By Type, 2018 - 2030 (USD Million)
• Table 185 Kuwait Population Screening Market, By Age, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Population screening market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Commodity flow approach
• Fig. 10 Market snapshot (2022) (USD Million)
• Fig. 11 Segment Snapshot (2022) (USD Million)
• Fig. 12 Segment Snapshot (2022) (USD Million)
• Fig. 13 Segment Snapshot (2022) (USD Million)

Fig. 14 Market Outlook (2022) (USD Million)

• Fig. 15 Penetration & growth prospect mapping
• Fig. 16 Population screening market driver impact
• Fig. 17 Global cancer cases projection, 2020-2030 (Number of newly registered cases)
• Fig. 18 Distinguishing screening from early diagnosis of cancer according to symptom onset
• Fig. 19 Elderly population total, % of the global population
• Fig. 20 Population screening market restraint impact
• Fig. 21 PESTEL analysis
• Fig. 22 Porter's Five Forces analysis
• Fig. 23 Population screening geography outlook: Key takeaways
• Fig. 24 Population screening market: Geography movement analysis
• Fig. 25 Nation market 2018 - 2030 (USD Million)
• Fig. 26 State market, 2018 - 2030 (USD Million)
• Fig. 27 Population screening product analysis outlook: Key takeaways
• Fig. 28 Population screening market: Product movement analysis
• Fig. 29 Hardware and Equipment market, 2018 - 2030 (USD Million)
• Fig. 30 Testing/lab (services) market, 2018 - 2030 (USD Million)
• Fig. 31 Analytics/interpretation market, 2018 - 2030 (USD Million)
• Fig. 32 Population screening business outlook: Key takeaways
• Fig. 33 Population screening market: business analysis
• Fig. 34 Hospitals market, 2018 - 2030 (USD Million)
• Fig. 35 Research institute market, 2018 - 2030 (USD Million)
• Fig. 36 Diagnostic labs market, 2018 - 2030 (USD Million)
• Fig. 37 Population screening gender outlook: Key takeaways
• Fig. 38 Population screening market: Gender analysis
• Fig. 39 Male market, 2018 - 2030 (USD Million)
• Fig. 40 Current screening statistics CDC (2022)
• Fig. 41 Female market, 2018 - 2030 (USD Million)
• Fig. 42 Population screening type outlook: Key takeaways
• Fig. 43 Population screening market: Type analysis
• Fig. 44 Mass market, 2018 - 2030 (USD Million)
• Fig. 45 Premium market, 2018 - 2030 (USD Million)
• Fig. 46 Population screening age outlook: Key takeaways
• Fig. 47 Population screening market: Age analysis
• Fig. 48 Ages 15 market, 2018 - 2030 (USD Million)
• Fig. 49 15-65 years market, 2018 - 2030 (USD Million)
• Fig. 50 Ages 65+ years market, 2018 - 2030 (USD Million)
• Fig. 51 Regional snapshot, 2021 & 2030
• Fig. 52 Regional marketplace: Key takeaways
• Fig. 53 Crude & effective coverage for cervical cancer screening across women aged 25 - 64
• Fig. 54 Global population screening market, 2018 - 2030 (USD Million)
• Fig. 55 North America population screening market, 2018 - 2030 (USD Million)
• Fig. 56 Europe population screening market, 2018 - 2030 (USD Million)
• Fig. 57 Asia Pacific population screening market, 2018 - 2030 (USD Million)
• Fig. 58 Latin America population screening market, 2018 - 2030 (USD Million)
• Fig. 59 Middle East and Africa population screening market, 2018 - 2030 (USD Million)
• Fig. 60 GCC population screening market, 2018 - 2030 (USD Million)
• Fig. 61 Rest of GCC population screening market, 2018 - 2030 (USD Million)
• Fig. 62 UAE population screening market, 2018 - 2030 (USD Million)
• Fig. 63 Australia population screening market, 2018 - 2030 (USD Million)
• Fig. 64 Percentage of screening for chronic diseases in 2017 and 2020
• Fig. 65 Singapore population screening market, 2018 - 2030 (USD Million)
• Fig. 66 UK population screening market, 2018 - 2030 (USD Million)
• Fig. 67 Thailand population screening market, 2018 - 2030 (USD Million)
• Fig. 68 ASEAN countries population screening market, 2018 - 2030 (USD Million)
• Fig. 69 Recent company/competition categorization